ZW25379A1 - Method for controlling hypertension and intestinal disorders and compositions - Google Patents

Method for controlling hypertension and intestinal disorders and compositions

Info

Publication number
ZW25379A1
ZW25379A1 ZW253/79A ZW25379A ZW25379A1 ZW 25379 A1 ZW25379 A1 ZW 25379A1 ZW 253/79 A ZW253/79 A ZW 253/79A ZW 25379 A ZW25379 A ZW 25379A ZW 25379 A1 ZW25379 A1 ZW 25379A1
Authority
ZW
Zimbabwe
Prior art keywords
compositions
intestinal disorders
controlling hypertension
hypertension
controlling
Prior art date
Application number
ZW253/79A
Inventor
C R Rasmussen
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of ZW25379A1 publication Critical patent/ZW25379A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZW253/79A 1978-12-22 1979-12-21 Method for controlling hypertension and intestinal disorders and compositions ZW25379A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions

Publications (1)

Publication Number Publication Date
ZW25379A1 true ZW25379A1 (en) 1981-07-22

Family

ID=27130555

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW253/79A ZW25379A1 (en) 1978-12-22 1979-12-21 Method for controlling hypertension and intestinal disorders and compositions

Country Status (23)

Country Link
AT (1) AT373878B (en)
AU (2) AU532332B2 (en)
CA (1) CA1127651A (en)
CH (1) CH647236A5 (en)
DE (1) DE2951213A1 (en)
DK (1) DK548179A (en)
ES (1) ES487159A0 (en)
FI (1) FI66354C (en)
FR (2) FR2444462B1 (en)
GB (2) GB2040681B (en)
GR (1) GR68018B (en)
HU (1) HU183013B (en)
IL (1) IL59019A (en)
IT (1) IT1126839B (en)
NL (1) NL7909265A (en)
NO (1) NO794249L (en)
NZ (1) NZ192453A (en)
PH (1) PH16571A (en)
PT (1) PT70624A (en)
SE (1) SE7910612L (en)
SU (1) SU971098A3 (en)
YU (1) YU314979A (en)
ZW (1) ZW25379A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL288408A (en) * 1960-08-05
FR1296962A (en) * 1960-08-05 1962-06-22 Geigy Ag J R New 2-imino-1.3-di-aza compounds and their preparation

Also Published As

Publication number Publication date
AU532332B2 (en) 1983-09-29
GB2113204B (en) 1984-02-01
ES8101558A1 (en) 1980-12-16
CH647236A5 (en) 1985-01-15
PT70624A (en) 1980-01-01
FR2444462A1 (en) 1980-07-18
GB2113204A (en) 1983-08-03
FI66354C (en) 1984-10-10
GB2040681A (en) 1980-09-03
GR68018B (en) 1981-10-27
NL7909265A (en) 1980-06-24
FR2445321A1 (en) 1980-07-25
HU183013B (en) 1984-04-28
FR2444462B1 (en) 1986-08-29
YU314979A (en) 1983-02-28
GB2040681B (en) 1983-04-13
DK548179A (en) 1980-06-23
AU5378079A (en) 1980-06-26
AU1640083A (en) 1983-11-17
FI794036A (en) 1980-06-23
PH16571A (en) 1983-11-18
IL59019A0 (en) 1980-03-31
FR2445321B1 (en) 1983-08-26
ATA808979A (en) 1983-07-15
DE2951213A1 (en) 1980-07-10
FI66354B (en) 1984-06-29
NZ192453A (en) 1982-09-07
SU971098A3 (en) 1982-10-30
CA1127651A (en) 1982-07-13
ES487159A0 (en) 1980-12-16
IT1126839B (en) 1986-05-21
NO794249L (en) 1980-06-24
SE7910612L (en) 1980-06-23
IL59019A (en) 1984-05-31
IT7951164A0 (en) 1979-12-21
AT373878B (en) 1984-02-27
AU566013B2 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
JPS5549473A (en) Method and circuit for controlling doorroperating unit
IL58017A0 (en) Method and composition for treating cardiovascular diseases
JPS551088A (en) Dielectric composition and dielectric stress controller
IL66069A0 (en) Compositions for treating glaucoma
JPS54111071A (en) Apparatus for controlling expansion condition of time constant
AU571184B2 (en) Compositions and methods for treating circulation disorders using protoberberines
GB2131811B (en) Microbial 1, 2-dehydrogenation of steroids
JPS5536183A (en) Headlight controller and controlling method
IL66070A0 (en) Compositions for treating glaucoma
PH13504A (en) Method of treating hypertension
GB2112786B (en) Compositions for treating glaucoma
ZA796965B (en) Method for controlling hypertension and intestinal disorders and compositions
ZW25379A1 (en) Method for controlling hypertension and intestinal disorders and compositions
AU567114B2 (en) Process for pearling sulfur
ZA835502B (en) Novel resolved keto compounds and process
GB2046538B (en) Time delay circuits for controlling lights
JPS5556070A (en) Refractory structure repairing method
PH17784A (en) Method for controlling hypertension
JPS54144561A (en) Method of controlling vibrating matter
JPS5588745A (en) Method of controlling computerrtomography device
DE3276270D1 (en) Apparatus and method for controlling consistency
AU538599B2 (en) Compositions and treatment for hypertension
JPS5495935A (en) Pour controlling method
JPS5495934A (en) Pour controlling method
GB2142772B (en) Apparatus for the continuous treatment of fragmented fuel elements